Clinical Trials Logo
  1. Home
  2. Head & Neck Cancer
  3. NCT01951664

Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors

Head Neck Cancer Clinical Trial

Official title:
Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors

Clinical Trial Summary

Treatment for head and neck cancer can result in marked musculo-skeletal impairment (MSI). This study will examine the effects of Hatha Yoga as a therapeutic modality to address MSI.

Clinical Trial Description

The use of aggressive treatment for head and neck cancer (HNC) particularly combined modality treatment regimens has resulted in an increase in survival. Unfortunately, this improvement has come with a marked increase in acute and late-effects. Acute HNC treatment-related toxicities have been clearly and extensively documented; however, data pertaining to adverse late-effects, those most likely to impact the survivor's long term symptom burden, functionality, and overall quality of life (QOL), are limited. This pilot study will be conducted to examine the feasibility of tailored Hatha Yoga as a therapeutic modality to address MSI in patients who have survived HNC. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01951664
Study type Interventional
Source Vanderbilt-Ingram Cancer Center
Contact
Status Completed
Phase N/A
Start date August 2013
Completion date October 2015
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04566367 - Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer N/A
Terminated NCT02521870 - A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Phase 1/Phase 2
Recruiting NCT05572684 - A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT02268344 - Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection N/A
Terminated NCT00198328 - Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma Phase 3
Recruiting NCT04858269 - First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients Phase 2
Recruiting NCT05878964 - Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
Recruiting NCT03051269 - Calcium Electroporation for Head and Neck Cancer Phase 1
Completed NCT05833841 - Swallowing Function in Patients With Head and Neck Cancers N/A
Withdrawn NCT03747562 - Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. Phase 3
Completed NCT03572829 - Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC Phase 2
Completed NCT02075385 - Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer Phase 2
Recruiting NCT02549742 - Electrochemotherapy on Head and Neck Cancer Phase 2
Recruiting NCT05838729 - Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer Phase 1/Phase 2
Completed NCT03832686 - Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer N/A
Recruiting NCT05382585 - Newer Therapeutic Targets in Head and Neck Cancers